CanSino Biologics Inc (HKG: 06185), known in English as CANSINOBIO, has announced that its board of directors has resolved to grant a total of 287,400 restricted shares to 19 eligible incentive recipients.
The grants are scheduled to be made on September 16, 2026, designated as the reserved grant date, with an exercise price of RMB 41.20 per A-share. This allotment falls under the reserved grant portion of the company's 2025 A-share incentive plan.